Arleigh McCurdy

13PUBLICATIONS
60CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ReproductionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 26, 2026
Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

|Jan 27, 2026
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Sita Bhella, Gerard Agbayani, Katrina Hueniken

|Jan 06, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.

Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi

|Nov 21, 2025
Reproductive autonomy of women living with multiple myeloma participating in a pregnancy prevention program.

J M Wigle, M Ramasamy, A McCurdy

|Sep 30, 2024
Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis.

Mohammad S Ebraheem, Rajshekhar Chakraborty, Bram Rochwerg

|Sep 11, 2024
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.

Arleigh McCurdy, Donna Reece, Martha L Louzada

Pageof 3

Frequent Collaborators

8 joint publications

Hira Mian

5 joint publications

Donna Reece

3 joint publications

Engin Gul

2 joint publications

Lisa K Hicks